Perna et al. report expression of all four on over 75% of AML cells [21], whereas Shahswar et al. observed lower frequencies for CCR1 and LILRB2, restricted to subsets of patients [32]. The gene discussed is LILRB2; the disease is acute myeloid leukemia.